0001104659-23-073743.txt : 20230622
0001104659-23-073743.hdr.sgml : 20230622
20230622160640
ACCESSION NUMBER: 0001104659-23-073743
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230620
FILED AS OF DATE: 20230622
DATE AS OF CHANGE: 20230622
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hambleton Julie
CENTRAL INDEX KEY: 0001578771
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39044
FILM NUMBER: 231033386
MAIL ADDRESS:
STREET 1: C/O FIVE PRIME THERAPEUTICS, INC.
STREET 2: TWO CORPORATE DRIVE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SpringWorks Therapeutics, Inc.
CENTRAL INDEX KEY: 0001773427
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 WASHINGTON BOULEVARD
CITY: STAMFORD
STATE: CT
ZIP: 06902
BUSINESS PHONE: 203-883-9490
MAIL ADDRESS:
STREET 1: 100 WASHINGTON BOULEVARD
CITY: STAMFORD
STATE: CT
ZIP: 06902
4
1
tm2319378-1_4seq1.xml
OWNERSHIP DOCUMENT
X0407
4
2023-06-20
0
0001773427
SpringWorks Therapeutics, Inc.
SWTX
0001578771
Hambleton Julie
C/O SPRINGWORKS THERAPEUTICS, INC.
100 WASHINGTON BLVD.
STAMFORD
CT
06902
1
0
0
0
1
Common Stock
2023-06-20
4
S
0
2400
26.9180
D
7066
D
The sales reported on this Form 4 were effected pursuant to a trading plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, adopted on March 17, 2023.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.44 to $27.40. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
/s/ Francis I. Perier, Jr. as Attorney-in Fact
2023-06-22